Aisling Capital, Others Inject $48M Into Roka Bioscience
Roka closed on $27.5 million of the financing in December and expects to complete the round later this year, bringing the company's total amount raised to $104.7 million since its founding in September 2009.
The terms of the financing were not disclosed.
“We are very pleased with...
To view the full article, register now.